GSK Doesn’t Have To Explain COVID Vax Claims For Moderna – Legal Ruling

By Editorial Team

The special master overseeing GlaxoSmithKline’s patent infringement lawsuit against Moderna’s COVID-19 vaccines has denied Moderna’s request for GSK to provide more detailed allegations. The order was made public on Wednesday.

Moderna had sought further clarification from GSK regarding its claims related to the COVID-19 vaccines. However, the special master’s ruling means that GSK is not obligated to provide additional explanations at this time.

The legal battle between GlaxoSmithKline and Moderna involves several patents related to the delivery of RNA to trigger immune responses and lipid formulations with immunogens. The case is being closely monitored by legal experts and industry observers.

For more information and updates on this developing legal matter, stay tuned to Law360 for comprehensive coverage and analysis.